Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 1999;85:1186-1191

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Methods
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lijnen, H. R.
Right arrow Articles by Collen, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lijnen, H. R.
Right arrow Articles by Collen, D.
(Circulation Research. 1999;85:1186.)
© 1999 American Heart Association, Inc.


Integrative Physiology

Tissue Inhibitor of Matrix Metalloproteinases-1 Impairs Arterial Neointima Formation After Vascular Injury in Mice

H. R. Lijnen, P. Soloway, D. Collen

From the Center for Molecular and Vascular Biology (H.R.L., D.C.), University of Leuven, Belgium, and Roswell Park Cancer Institute (P.S.), Buffalo, NY.

Correspondence to H.R. Lijnen, Center for Molecular and Vascular Biology, University of Leuven, Campus Gasthuisberg, O & N, Herestraat 49, B-3000 Leuven, Belgium. E-mail roger.lijnen{at}med.kuleuven.ac.be

Abstract—The hypothesis that tissue inhibitor of metalloproteinases-1 (TIMP-1) plays a role in neointima formation was tested with the use of a vascular injury model in wild-type (TIMP-1+/+) and TIMP-1–deficient (TIMP-1-/-) mice. The neointimal area at 1 to 3 weeks after electric injury of the femoral artery was significantly higher in TIMP-1-/- as compared with TIMP-1+/+ mice (0.012±0.0015 versus 0.0033±0.0008 mm2 at 1 week, P<0.005). The medial areas were comparable, resulting in intima/media ratios that were significantly larger in TIMP-1-/- as compared with TIMP-1+/+ arteries (1.2±0.22 versus 0.39±0.08 at 1 week, P<0.005). Nuclear cell counts in cross-sectional areas of the intima of the injured region were higher in TIMP-1-/- as compared with TIMP-1+/+ arteries (138±15 versus 69±8 at 1 week, P<0.005). Immunocytochemical analysis revealed that {alpha}-actin–positive smooth muscle cells (SMCs) at 2 weeks after injury were more abundant in the intima of TIMP-1-/- arteries than in that of TIMP-1+/+ arteries, whereas after 3 weeks the intimal cell population consisted mainly of SMCs in both genotypes. In in vitro scrape-wounding assays, SMCs of TIMP-1-/- mice migrated faster than those of TIMP-1+/+ mice. Zymography of arterial extracts revealed a higher active matrix metalloproteinase (MMP)–2 level at 1 to 3 weeks after injury in TIMP-1-/- arteries, whereas active MMP-9 was only detected in TIMP-1-/- arteries at 1 week after injury. These data are compatible with a role of TIMP-1 in the impairment of SMC migration and neointima formation after vascular injury, as a result of inhibition of MMP activity.


Key Words: matrix metalloproteinase • TIMP • vascular injury • restenosis • gene-deficient mice




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
M. Ogawa, J.-i. Suzuki, K. Hishikari, K. Takayama, H. Tanaka, and M. Isobe
Clarithromycin Attenuates Acute and Chronic Rejection Via Matrix Metalloproteinase Suppression in Murine Cardiac Transplantation
J. Am. Coll. Cardiol., May 20, 2008; 51(20): 1977 - 1985.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. L. Johnson, R. Fritsche-Danielson, M. Behrendt, A. Westin-Eriksson, H. Wennbo, M. Herslof, M. Elebring, S. J. George, W. L. McPheat, and C. L. Jackson
Effect of broad-spectrum matrix metalloproteinase inhibition on atherosclerotic plaque stability
Cardiovasc Res, August 1, 2006; 71(3): 586 - 595.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Lee, J. Frischer, A. Serur, J. Huang, J.-O Bae, Z. N. Kornfield, L. Eljuga, C. J. Shawber, N. Feirt, M. Mansukhani, et al.
Inhibition of cyclooxygenase-2 disrupts tumor vascular mural cell recruitment and survival signaling.
Cancer Res., April 15, 2006; 66(8): 4378 - 4384.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Janssens and H. R. Lijnen
What has been learned about the cardiovascular effects of matrix metalloproteinases from mouse models?
Cardiovasc Res, February 15, 2006; 69(3): 585 - 594.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
K. Kobayashi, K. Yokote, M. Fujimoto, K. Yamashita, A. Sakamoto, M. Kitahara, H. Kawamura, Y. Maezawa, S. Asaumi, T. Tokuhisa, et al.
Targeted Disruption of TGF-{beta}-Smad3 Signaling Leads to Enhanced Neointimal Hyperplasia With Diminished Matrix Deposition in Response to Vascular Injury
Circ. Res., April 29, 2005; 96(8): 904 - 912.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
A. C. Newby
Dual Role of Matrix Metalloproteinases (Matrixins) in Intimal Thickening and Atherosclerotic Plaque Rupture
Physiol Rev, January 1, 2005; 85(1): 1 - 31.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. Zahradka, G. Harding, B. Litchie, S. Thomas, J. P. Werner, D. P. Wilson, and N. Yurkova
Activation of MMP-2 in response to vascular injury is mediated by phosphatidylinositol 3-kinase-dependent expression of MT1-MMP
Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2861 - H2870.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
P. C. Saunders, G. Pintucci, C. S. Bizekis, R. Sharony, K. M. Hyman, F. Saponara, F. G. Baumann, E. A. Grossi, S. B. Colvin, P. Mignatti, et al.
Vein graft arterialization causes differential activation of mitogen-activated protein kinases
J. Thorac. Cardiovasc. Surg., May 1, 2004; 127(5): 1276 - 1284.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
J. S. Forrester
Prevention of Plaque Rupture: A New Paradigm of Therapy
Ann Intern Med, November 19, 2002; 137(10): 823 - 833.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. Cho and M. A. Reidy
Matrix Metalloproteinase-9 Is Necessary for the Regulation of Smooth Muscle Cell Replication and Migration After Arterial Injury
Circ. Res., November 1, 2002; 91(9): 845 - 851.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. Silence, D. Collen, and H.R. Lijnen
Reduced Atherosclerotic Plaque but Enhanced Aneurysm Formation in Mice With Inactivation of the Tissue Inhibitor of Metalloproteinase-1 (TIMP-1) Gene
Circ. Res., May 3, 2002; 90(8): 897 - 903.
[Abstract] [Full Text] [PDF]


Home page
Vasc MedHome page
I. Loftus and M. Thompson
The role of matrix metalloproteinases in vascular disease
Vascular Medicine, May 1, 2002; 7(2): 117 - 133.
[Abstract] [PDF]


Home page
CirculationHome page
L. J. Feldman, M. Mazighi, A. Scheuble, J.-F. Deux, E. De Benedetti, C. Badier-Commander, E. Brambilla, D. Henin, P. G. Steg, and M.-P. Jacob
Differential Expression of Matrix Metalloproteinases After Stent Implantation and Balloon Angioplasty in the Hypercholesterolemic Rabbit
Circulation, June 26, 2001; 103(25): 3117 - 3122.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. Vieillard-Baron, E. Frisdal, S. Eddahibi, I. Deprez, A. H. Baker, A. C. Newby, P. Berger, M. Levame, B. Raffestin, S. Adnot, et al.
Inhibition of Matrix Metalloproteinases by Lung TIMP-1 Gene Transfer or Doxycycline Aggravates Pulmonary Hypertension in Rats
Circ. Res., September 1, 2000; 87(5): 418 - 425.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. Silence, D. Collen, and H.R. Lijnen
Reduced Atherosclerotic Plaque but Enhanced Aneurysm Formation in Mice With Inactivation of the Tissue Inhibitor of Metalloproteinase-1 (TIMP-1) Gene
Circ. Res., May 3, 2002; 90(8): 897 - 903.
[Abstract] [Full Text] [PDF]